Nigeria has one of the largest African populations living in a holoendemic malaria transmission area. Therefore, it has a high malaria burden and a high demand for antimalarials. Due to its shared borders and substantial pharmaceutical manufacturing industry, it is a strong model to monitor cross-border market issues. Nigeria was one of the pilot countries for the AMFm "factory-gate" subsidy for ACTs from 2010-2013.

As of 2016, ACTwatch has conducted four outlet surveys (2009, 2011, 2013, and 2015), two household surveys (2009 and 2012), as well as qualitative and quantitative supply chain research (2009) in Nigeria. The 2013 outlet survey report is available here. The results from the 2015 outlet survey will be available soon.

National Primary Health Care Development Agency, Abuja

Published reports